Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Nov 2023 for Eiger BioPharmaceuticals, Inc., €3,041.
Filing timeline
BuySaleLeen Kawas
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Leen Kawas: trading record in brief
Leen Kawas appears in our data through filings on Eiger BioPharmaceuticals, Inc. shares, published by SEC (Form 4). We count 2 filings, every one of them for a trade on 31 October 2023.
On the market, this insider has only ever bought: 2 purchases, €6,005 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 2 November 2023 came the latest disclosure, an open-market purchase for €3,041 in Eiger BioPharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Leen Kawas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
12,345 shares@ US$0.261550.6% of flowCommon StockSEC:0001140361-23-051260:1
Canonical exit: 29 Jan 2024 (T+90)
11,987 shares@ US$0.2625100.0% of flowCommon StockSEC:0001140361-23-051260:0
Canonical exit: 29 Jan 2024 (T+90)
2 of 2 declarations
